ArticleThe Journal of infectious diseases2026
Is it "Time to Eliminate" Time to Elimination of Symptoms as a Primary Trial End Point for Drugs Targeting Respiratory Viruses?
Joshua T Schiffer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.